Immunohistochemical Expression of Cyclin D1 in Invasive Breast Carcinoma

Immunohistochemical Expression of Cyclin D1 in Invasive Breast Carcinoma

Objective: This study was conducted to determine the immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its association with already established prognostic parameters like estrogen receptor (ER), progesterone receptor (PR), HER2/Neu, and Ki67 status. Study Design &a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tabish Hassan, Nadeem Zafar, Akhter Ali Bajwa, Rabia Ahmed, Muhammad Umair, Mubina Qayyum
Format:	Article
Language:	English
Published:	Bahria Univerisy Health Sciences, Campus Karachi 2024-10-01
Series:	Journal of Bahria University Medical and Dental College
Subjects:	breast carcinoma; cyclin d1; er; pr; her2; ki67
Online Access:	https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/1581
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Clinically Relevant Markers in a Patient-Derived Xenograft Model of Triple-Negative Breast Cancer
by: I. S. Lyashenko, et al.
Published: (2025-05-01)

دراسة بعض الماركرات في النساء العراقيات المريضات بسرطان الثدي
by: Abeer M. Hussain, et al.
Published: (2021-12-01)

Expression of ER, PR and Ki-67 in tumor with different genetic variants of ESR and levels of antiidiotypic antibodies to steroid hormones in breast cancer patients
by: A. N. Glushkov, et al.
Published: (2024-12-01)

The optimal treatment of invasive ductal and lobular carcinoma occurring at the same time needs to be established
by: Supriya Peshin, et al.
Published: (2025-01-01)

Immunohistochemical characteristics of breast cancer, increasing the risk of local reccurence after organosaving treatment
by: S. M. Demidov, et al.
Published: (2018-10-01)

Real-World, National Study of Palbociclib in HR+/HER2− Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021
by: Cristina Marinela Oprean, et al.
Published: (2025-05-01)

Phosphohistone H3 as the standard of immunohistochemical study in the assessment of differentiation level of oropharyngeal zone squamous cell carcinomas
by: А. V. Lysak, et al.
Published: (2016-08-01)

Potential of Proliferative Markers in Pancreatic Cancer Management: A Systematic Review
by: Aryan Salahi‐Niri, et al.
Published: (2025-03-01)

Immunohistochemical Expression of ROS1 in invasive ductal carcinoma of breast in association with hormonal receptor status and Her2Neu expression
by: Muhammad Umair, et al.
Published: (2024-10-01)

Morphological and immunohistochemical analysis in encapsulated follicular variant papillary thyroid carcinoma, invasive follicular variant papillary thyroid carcinoma and a new entity: non-invasive follicular thyroid neoplasm with papillary nuclear feature
by: Zeliha Çelik, et al.
Published: (2024-12-01)

Assessment of the Relationship between Ki-67 Expression and Different Clinicopathological Factors of Adenoid Cystic Carcinoma: A Retrospective Immunohistochemical Study
by: Mohammed Al Zubidi, et al.
Published: (2025-03-01)

Immunohistochemical expression of markers Ki-67, neun, synaptophysin, p53 and HER2 in medulloblastoma and its correlation with clinicopathological parameters Expressão imunoistoquímica dos marcadores Ki-67, neun, sinaptofisina, p53 e HER2 em meduloblastoma e sua correlação com os parâmetros clínico-patológicos
by: Rosalva Thereza Meurer, et al.
Published: (2008-06-01)

Immunohistochemical Study of Ki-67 and HER2/neu and its Correlation with Clinicopathological Features in Surface Epithelial Tumors of the Ovary
by: Sameeksha Alva, et al.
Published: (2025-01-01)

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01)

Histologic and immunohistochemical evaluation of mirror image biopsies in oral squamous cell carcinoma
by: Vineet Gupta, et al.
Published: (2016-09-01)

Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: A randomized controlled clinical trial
by: Samar A. Dewidar, et al.
Published: (2022-10-01)

Immunohistochemical Staining Properties of Osteopontin and Ki-67 in Feline Meningiomas
by: Gabriele Gradner, et al.
Published: (2024-11-01)

Study of Immunohistochemical Expression of p53 and Ki-67 in Oral Squamous Cell Carcinoma
by: Kajal Ranjan, et al.
Published: (2025-08-01)

Clinicopathological importance of immunohistochemical expression of OCT4, c-MYC and Ki-67 in colorectal cancer
by: Rabia Hursitoglu, et al.
Published: (2024-12-01)

Immunohistochemical Changes of Polycystic Ovaries in rats Treated with Asparagus Officinalis L. Roots Extract
by: Farah Jawad Al-masoudi, et al.
Published: (2024-09-01)

Comparison of immunohistochemical characteristics of prognostic markers expression in non-metastatic and metastatic invasive endometrioid endometrial carcinoma
by: A. V. Chepets
Published: (2016-10-01)

Assessment of ESR1, PGR, ERBB2, and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
by: Hamid Rezvani, et al.
Published: (2025-07-01)

Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study
by: Susnata Khan, et al.
Published: (2024-10-01)

Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)

Features of expression of immunohistochemical markers in local and generalized clear cell kidney cancer
by: E. M. Frantsiyants, et al.
Published: (2020-03-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Relationship between immunohistochemical markers and clinical pathological variables in clear cell renal cell carcinoma
by: Pengshuai Liu, et al.
Published: (2025-08-01)

Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01)

Immunohistochemical features of ovarian structure at polycystic ovary syndrom depending on the age
by: I. Yu. Ganzhiy
Published: (2012-12-01)

Effect of expression of immunohistochemical marker Ki-67 on the life expectancy of patients with gastric cancer 0-III stages
by: O. M. Levyk, et al.
Published: (2015-08-01)

Comparative immunohistochemical characteristics of expression of estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma and normal proliferative endometrium
by: V. A. Tumanskiy, et al.
Published: (2016-04-01)

Pathogenetic aspects of treatment of patients with genital endometriosis and syndrome of chronic pelvic pain in combination with "proliferative genital syndrome".
by: L. Grek
Published: (2018-06-01)

Notch1 and CyclinD1 expression and significance in jaw ameloblastoma: an immunohistochemical analysis
by: Baoyinbatu Gabiyatu, et al.
Published: (2025-07-01)

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
by: Yu. S. Krumin, et al.
Published: (2021-03-01)

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
by: Taha Heba F., et al.
Published: (2021-05-01)

A deep learning model to predict Ki-67 positivity in oral squamous cell carcinoma
by: Francesco Martino, et al.
Published: (2024-12-01)

Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01)

Current aspects of systematics, diagnosis and treatment of breast cancer
by: D. N. Strunkin, et al.
Published: (2022-05-01)

Papillary squamotransitional cell carcinoma of the uterine cervix: A histomorphological and immunohistochemical study of nine cases
by: Mani Anand, et al.
Published: (2013-01-01)

CDX2 expression in gastric carcinoma: A clinicopathological study
by: Aniket Halder, et al.
Published: (2018-01-01)